Celia Vélez
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 3
-
- Congenital heart defects research 9
- Retinoids in leukemia and cellular processes 4
- Co-authors
- Consolación Melguizo (38 shared papers)Jose Carlos Prados (32 shared papers)Antonia Aránega (34 shared papers)Pablo Juan Alvarez (7 shared papers)Juan Antonio Marchal (18 shared papers)Raúl Ortíz (10 shared papers)Houría Boulaiz (14 shared papers)Esmeralda Carrillo (12 shared papers)
- Journals
- Cells Tissues Organs (5 papers)International Journal of Molecular Sciences (2 papers)Life Sciences (2 papers)Journal of Cardiovascular Pharmacology (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- SpainItalyUnited States
In The Last Decade
Celia Vélez
47 papers receiving 650 citations
Peers
Comparison fields: 5 of 76
- Biomaterials 130
- Drug Discovery 2
- Oncology 84
- Pharmaceutical Science 22
- Molecular Biology 183
Countries citing papers authored by Celia Vélez
This map shows the geographic impact of Celia Vélez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia Vélez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia Vélez more than expected).
Fields of papers citing papers by Celia Vélez
This network shows the impact of papers produced by Celia Vélez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia Vélez. The network helps show where Celia Vélez may publish in the future.
Co-authors
The 25 scholars most cited alongside Celia Vélez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 115 | |
| 2 | 2012 | 103 | |
| 3 | 2013 | 43 | |
| 4 | 2015 | 34 | |
| 5 | 2016 | 30 | |
| 6 | 2003 | 25 | |
| 7 | 2009 | 21 | |
| 8 | 1995 | 19 | |
| 9 | 1997 | 19 | |
| 10 | 1998 | 15 | |
| 11 | 2015 | 15 | |
| 12 | 2019 | 15 | |
| 13 | Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line. | 1994 | 13 |
| 14 | 2010 | 13 | |
| 15 | 1993 | 12 | |
| 16 | 1999 | 12 | |
| 17 | 2007 | 12 | |
| 18 | 2012 | 12 | |
| 19 | 2022 | 12 | |
| 20 | 1995 | 11 |
About Celia Vélez
Celia Vélez is a scholar working on Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine, Cell Biology and Biotechnology, having authored 49 papers that have together received 678 indexed citations. Recurring topics across this work include Congenital heart defects research (9 papers), Sarcoma Diagnosis and Treatment (6 papers), Cardiomyopathy and Myosin Studies (5 papers), Virus-based gene therapy research (4 papers), Skin and Cellular Biology Research (4 papers), Retinoids in leukemia and cellular processes (4 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Biomaterials (130 citations), Drug Discovery (2 citations), Oncology (84 citations), Pharmaceutical Science (22 citations) and Molecular Biology (183 citations). Celia Vélez has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include Consolación Melguizo, Jose Carlos Prados, Antonia Aránega, Pablo Juan Alvarez, Juan Antonio Marchal, Raúl Ortíz, Houría Boulaiz, Esmeralda Carrillo, Fernando Rodríguez‐Serrano and José Luis Arias Mediano. Their work appears in journals such as Cells Tissues Organs, International Journal of Molecular Sciences, Life Sciences, Journal of Cardiovascular Pharmacology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.